US Stock MarketDetailed Quotes

JAGX Jaguar Health

Watchlist

5.8550
-1.8310-23.82%

Trading May 23 13:19 ET

28.63MMarket Cap0.18P/E (TTM)

Jaguar Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.14%-7.05M

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

-5.55%-10.46M

Net income from continuing operations

27.54%-9.15M

14.68%-41.87M

-2.63%-9.15M

36.66%-7.99M

-28.95%-12.11M

30.47%-12.63M

6.70%-49.08M

37.76%-8.91M

-3.42%-12.61M

33.31%-9.39M

Operating gains losses

-4,064.52%-1.23M

-266.71%-3.65M

1,000.00%9K

-369,300.00%-3.69M

100.96%6K

-98.90%31K

-10.22%2.19M

---1K

--1K

-465.12%-628K

Depreciation and amortization

10.71%610K

4.19%2.39M

-1.83%591K

6.47%625K

-4.17%621K

21.10%551K

26.42%2.29M

25.94%602K

24.10%587K

50.35%648K

Other non cash items

-81.00%274K

6.33%13.38M

-45.31%1.72M

124.06%7.09M

10.36%3.13M

-58.12%1.44M

142.55%12.58M

103.90%3.14M

159.69%3.16M

130.25%2.84M

Change In working capital

14.53%-153K

-150.65%-11.1M

-43.51%-3.33M

-2,221.58%-5.6M

53.86%-2M

-107.28%-179K

-295.32%-4.43M

-220.59%-2.32M

63.54%-241K

-621.45%-4.33M

-Change in receivables

-54.85%465K

170.78%298K

-1,145.16%-324K

28.16%-296K

-168.71%-112K

607.39%1.03M

-117.43%-421K

-49.18%31K

-120.92%-412K

-90.70%163K

-Change in inventory

110.18%169K

-1.93%-2.17M

-91.49%-810K

-179.86%-115K

122.50%420K

-7,645.45%-1.66M

-0.28%-2.12M

-9.30%-423K

112.96%144K

-221.34%-1.87M

-Change in prepaid assets

-610.00%-1.14M

-221.22%-5.01M

-668.81%-2.39M

2,079.66%1.17M

-113.79%-3.63M

-131.56%-160K

-95.98%-1.56M

-154.28%-311K

44.34%-59K

-176.38%-1.7M

-Change in payables and accrued expense

-265.54%-1.13M

-802.95%-3.81M

112.22%288K

-2,475.19%-6.22M

207.68%1.44M

-68.54%682K

-83.02%542K

-208.32%-2.36M

118.32%262K

100.43%469K

-Change in other current assets

4,183.33%735K

96.91%-17K

-99.64%3K

95.51%-4K

100.15%2K

-260.00%-18K

-34.80%-550K

289.89%845K

---89K

---1.3M

-Change in other current liabilities

-101.89%-107K

-25.08%-394K

9.62%-94K

-43.68%-125K

-28.42%-122K

-82.76%-53K

-1,557.89%-315K

-89.09%-104K

-611.76%-87K

-600.00%-95K

-Change in other working capital

--850K

----

Cash from discontinued investing activities

Operating cash flow

29.14%-7.05M

-0.42%-33.24M

-16.00%-7.45M

20.39%-6.79M

13.40%-9.06M

-29.24%-9.95M

5.34%-33.1M

28.02%-6.42M

9.57%-8.53M

-5.55%-10.46M

Investing cash flow

Cash flow from continuing investing activities

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

-1.26M

Net PPE purchase and sale

----

--0

----

-1,183.33%-77K

--0

---3K

---74K

Net intangibles purchase and sale

----

--0

----

---1.6M

---361K

---53K

---1.18M

Cash from discontinued investing activities

Investing cash flow

----

--0

----

-27,816.67%-1.68M

-103.45%-361K

99.47%-56K

---1.26M

Financing cash flow

Cash flow from continuing financing activities

-34.78%12.27M

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

3,022.15%10.15M

-66.27%3.25M

Net issuance payments of debt

22.38%-222K

-102.58%-100K

-377.78%-50K

--0

-67.76%236K

63.43%-286K

-57.20%3.88M

-96.94%18K

667.88%3.91M

670.53%732K

Net common stock issuance

-30.09%12.49M

56.88%32.1M

320.52%11.25M

-77.03%1.43M

-36.72%1.55M

96.10%17.87M

-39.06%20.46M

-17.15%2.68M

701.80%6.22M

-74.82%2.45M

Net preferred stock issuance

----

--611K

--0

----

--0

----

Proceeds from stock option exercised by employees

----

--1.24M

--1K

--0

----

--0

----

Net other financing activities

----

132.87%380K

47.54%-554K

-211.11%-20K

-563.33%-278K

792.13%1.23M

-58.14%-1.16M

-51.72%-1.06M

-93.59%18K

122.56%60K

Cash from discontinued financing activities

Financing cash flow

-34.78%12.27M

47.65%34.23M

550.18%10.65M

-86.11%1.41M

3.42%3.36M

130.81%18.81M

-47.24%23.18M

-47.52%1.64M

2,620.38%10.15M

-66.10%3.25M

Net cash flow

Beginning cash position

18.28%6.47M

-67.93%5.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

110.77%17.05M

-14.66%10.56M

-71.75%9.01M

-45.87%17.46M

Current changes in cash

-41.11%5.22M

108.49%985K

162.16%3.2M

-444.49%-5.38M

32.71%-5.7M

1,848.57%8.87M

-229.43%-11.6M

-210.05%-5.15M

108.00%1.56M

-2,405.62%-8.47M

Effect of exchange rate changes

-159.38%-19K

-6.25%15K

-18.52%44K

-33.33%-20K

-251.85%-41K

164.00%32K

--16K

--54K

---15K

--27K

End cash Position

-18.77%11.67M

18.28%6.47M

-69.45%3.23M

-4.29%8.63M

-17.70%14.37M

-67.93%5.47M

-14.66%10.56M

-71.75%9.01M

Free cash flow

29.14%-7.05M

4.42%-33.24M

-9.83%-7.45M

20.91%-6.79M

22.70%-9.06M

-29.24%-9.95M

0.56%-34.78M

23.97%-6.78M

8.98%-8.59M

-18.18%-11.72M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.14%-7.05M	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M	-5.55%-10.46M
Net income from continuing operations	27.54%-9.15M	14.68%-41.87M	-2.63%-9.15M	36.66%-7.99M	-28.95%-12.11M	30.47%-12.63M	6.70%-49.08M	37.76%-8.91M	-3.42%-12.61M	33.31%-9.39M
Operating gains losses	-4,064.52%-1.23M	-266.71%-3.65M	1,000.00%9K	-369,300.00%-3.69M	100.96%6K	-98.90%31K	-10.22%2.19M	---1K	--1K	-465.12%-628K
Depreciation and amortization	10.71%610K	4.19%2.39M	-1.83%591K	6.47%625K	-4.17%621K	21.10%551K	26.42%2.29M	25.94%602K	24.10%587K	50.35%648K
Other non cash items	-81.00%274K	6.33%13.38M	-45.31%1.72M	124.06%7.09M	10.36%3.13M	-58.12%1.44M	142.55%12.58M	103.90%3.14M	159.69%3.16M	130.25%2.84M
Change In working capital	14.53%-153K	-150.65%-11.1M	-43.51%-3.33M	-2,221.58%-5.6M	53.86%-2M	-107.28%-179K	-295.32%-4.43M	-220.59%-2.32M	63.54%-241K	-621.45%-4.33M
-Change in receivables	-54.85%465K	170.78%298K	-1,145.16%-324K	28.16%-296K	-168.71%-112K	607.39%1.03M	-117.43%-421K	-49.18%31K	-120.92%-412K	-90.70%163K
-Change in inventory	110.18%169K	-1.93%-2.17M	-91.49%-810K	-179.86%-115K	122.50%420K	-7,645.45%-1.66M	-0.28%-2.12M	-9.30%-423K	112.96%144K	-221.34%-1.87M
-Change in prepaid assets	-610.00%-1.14M	-221.22%-5.01M	-668.81%-2.39M	2,079.66%1.17M	-113.79%-3.63M	-131.56%-160K	-95.98%-1.56M	-154.28%-311K	44.34%-59K	-176.38%-1.7M
-Change in payables and accrued expense	-265.54%-1.13M	-802.95%-3.81M	112.22%288K	-2,475.19%-6.22M	207.68%1.44M	-68.54%682K	-83.02%542K	-208.32%-2.36M	118.32%262K	100.43%469K
-Change in other current assets	4,183.33%735K	96.91%-17K	-99.64%3K	95.51%-4K	100.15%2K	-260.00%-18K	-34.80%-550K	289.89%845K	---89K	---1.3M
-Change in other current liabilities	-101.89%-107K	-25.08%-394K	9.62%-94K	-43.68%-125K	-28.42%-122K	-82.76%-53K	-1,557.89%-315K	-89.09%-104K	-611.76%-87K	-600.00%-95K
-Change in other working capital	--850K	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	29.14%-7.05M	-0.42%-33.24M	-16.00%-7.45M	20.39%-6.79M	13.40%-9.06M	-29.24%-9.95M	5.34%-33.1M	28.02%-6.42M	9.57%-8.53M	-5.55%-10.46M
Investing cash flow
Cash flow from continuing investing activities		0	0	0			-27,816.67%-1.68M	-103.45%-361K	99.47%-56K	-1.26M
Net PPE purchase and sale	----	--0	--0	--0	----	----	-1,183.33%-77K	--0	---3K	---74K
Net intangibles purchase and sale	----	--0	--0	--0	----	----	---1.6M	---361K	---53K	---1.18M
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	----	----	-27,816.67%-1.68M	-103.45%-361K	99.47%-56K	---1.26M
Financing cash flow
Cash flow from continuing financing activities	-34.78%12.27M	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	3,022.15%10.15M	-66.27%3.25M
Net issuance payments of debt	22.38%-222K	-102.58%-100K	-377.78%-50K	--0	-67.76%236K	63.43%-286K	-57.20%3.88M	-96.94%18K	667.88%3.91M	670.53%732K
Net common stock issuance	-30.09%12.49M	56.88%32.1M	320.52%11.25M	-77.03%1.43M	-36.72%1.55M	96.10%17.87M	-39.06%20.46M	-17.15%2.68M	701.80%6.22M	-74.82%2.45M
Net preferred stock issuance	----	--611K	--0	--0	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	----	--1.24M	--1K	--0	----	----	--0	--0	--0	----
Net other financing activities	----	132.87%380K	47.54%-554K	-211.11%-20K	-563.33%-278K	792.13%1.23M	-58.14%-1.16M	-51.72%-1.06M	-93.59%18K	122.56%60K
Cash from discontinued financing activities
Financing cash flow	-34.78%12.27M	47.65%34.23M	550.18%10.65M	-86.11%1.41M	3.42%3.36M	130.81%18.81M	-47.24%23.18M	-47.52%1.64M	2,620.38%10.15M	-66.10%3.25M
Net cash flow
Beginning cash position	18.28%6.47M	-67.93%5.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	110.77%17.05M	-14.66%10.56M	-71.75%9.01M	-45.87%17.46M
Current changes in cash	-41.11%5.22M	108.49%985K	162.16%3.2M	-444.49%-5.38M	32.71%-5.7M	1,848.57%8.87M	-229.43%-11.6M	-210.05%-5.15M	108.00%1.56M	-2,405.62%-8.47M
Effect of exchange rate changes	-159.38%-19K	-6.25%15K	-18.52%44K	-33.33%-20K	-251.85%-41K	164.00%32K	--16K	--54K	---15K	--27K
End cash Position	-18.77%11.67M	18.28%6.47M	18.28%6.47M	-69.45%3.23M	-4.29%8.63M	-17.70%14.37M	-67.93%5.47M	-67.93%5.47M	-14.66%10.56M	-71.75%9.01M
Free cash flow	29.14%-7.05M	4.42%-33.24M	-9.83%-7.45M	20.91%-6.79M	22.70%-9.06M	-29.24%-9.95M	0.56%-34.78M	23.97%-6.78M	8.98%-8.59M	-18.18%-11.72M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall